Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of 39.39% is 99% above its 1-year average of 19.78%, near the high end of its 1-year range (-67.48%–63.06%).
99.11% above its 12-month average of 19.78%.
Reported quarterly EBITDA margin; no daily interpolation. Q4 FY2021 (2021-12-31): 63.06%.
EBITDA MARGIN
39.39%
EBITDA MARGIN AVG TTM
19.78%
EBITDA MARGIN AVG 3Y
N/A
EBITDA MARGIN AVG 5Y
N/A
EBITDA MARGIN AVG 10Y
N/A
EBITDA MARGIN AVG 15Y
N/A
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+99.11%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Atea Pharmaceuticals, Inc.
Market Cap
$405.74M
EBITDA Margin
39.39%
TTM Avg
19.78%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$406.58M
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$404.24M
EBITDA Margin
-1.71%
TTM Avg
-2.46%
3Y Avg
-6.59%
5Y Avg
-11.17%
Market Cap
$402.17M
EBITDA Margin
-8579.24%
TTM Avg
-8579.24%
3Y Avg
-8579.24%
5Y Avg
-8579.24%
Market Cap
$411.00M
EBITDA Margin
-7.84%
TTM Avg
-9.54%
3Y Avg
-19.72%
5Y Avg
-25.08%
Market Cap
$411.21M
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$397.99M
EBITDA Margin
-59.97%
TTM Avg
-74.12%
3Y Avg
-94.06%
5Y Avg
-94.06%
Market Cap
$396.93M
EBITDA Margin
-48.80%
TTM Avg
-44.09%
3Y Avg
-45.35%
5Y Avg
-45.35%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Atea Pharmaceuticals, Inc. (AVIR) | $405.74M | 39.39% | 19.78% | N/A | N/A |
| Eikon Therapeutics, Inc. Common Stock (EIKN)vs › | $406.58M | N/A | N/A | N/A | N/A |
| Myriad Genetics, Inc. (MYGN)vs › | $404.24M | -1.71% | -2.46% | -6.59% | -11.17% |
| Neurogene Inc. (NGNE)vs › | $402.17M | -8579.24% | -8579.24% | -8579.24% | -8579.24% |
| Strata Critical Medical, Inc. (SRTA)vs › | $411.00M | -7.84% | -9.54% | -19.72% | -25.08% |
| MapLight Therapeutics, Inc. (MPLT)vs › | $411.21M | N/A | N/A | N/A | N/A |
| Carlsmed, Inc. (CARL)vs › | $397.99M | -59.97% | -74.12% | -94.06% | -94.06% |
| Shoulder Innovations, Inc. (SI)vs › | $396.93M | -48.80% | -44.09% | -45.35% | -45.35% |
| Rezolute, Inc. (RZLT)vs › | $415.98M | N/A | N/A | N/A | N/A |
| Senseonics Holdings, Inc. (SENS)vs › | $416.27M | -189.54% | -258.01% | -315.18% | -540.94% |
Gross Margin
0.0%
EBITDA Margin
39.4%
Operating Margin
0.0%
Net Margin
0.0%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2021-12-31 | 63.06% |
| 2021-09-30 | -67.48% |
| 2021-06-30 | 14.40% |
| 2021-03-31 | 46.47% |
| 2020-12-31 | 42.47% |
